Q4 Earnings Estimate for STERIS’ Issued By Atb Cap Markets

STERIS’ (TSE:STE) – Equities researchers at Atb Cap Markets issued their Q4 2024 earnings per share estimates for shares of STERIS’ in a research report issued to clients and investors on Sunday, December 22nd. Atb Cap Markets analyst W. Syed anticipates that the company will post earnings of ($0.32) per share for the quarter. Atb Cap Markets has a “Strong-Buy” rating on the stock. Atb Cap Markets also issued estimates for STERIS’’s Q1 2025 earnings at $0.29 EPS, Q2 2025 earnings at $0.09 EPS, Q3 2025 earnings at $0.25 EPS, Q4 2025 earnings at ($0.20) EPS, FY2025 earnings at $0.43 EPS, Q1 2026 earnings at $0.39 EPS, Q2 2026 earnings at $0.11 EPS, Q3 2026 earnings at $0.30 EPS, FY2026 earnings at $0.63 EPS and FY2027 earnings at $0.76 EPS.

STERIS’ Stock Performance

About STERIS’

STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe by providing innovative healthcare and life science product and service solutions around the globe.